Domov › Rakovina endometria › Missouri
Klinické štúdie Rakovina endometria v štáte Missouri
31 štúdií pre Rakovina endometria hľadá účastníkov v zariadeniach v štáte Missouri.
Mestá v štáte Missouri
Oficiálny text štúdie (anglicky)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Saint Francis Medical Center, Cape Girardeau
- Saint Luke's Hospital, Chesterfield
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- a 13 ďalších
Prebieha náborFáza 2
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05564377A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Washington University Medicine, St Louis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06270706Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
- Mercy Hospital Springfield, Springfield
- CoxHealth South Hospital, Springfield
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 2. 10. 2026 · NCT07198074A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Washington University, School of Medicine, St Louis
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06172478Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
- Washington University School of Medicine, St Louis
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 28. 9. 2026 · NCT05112601Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, St Louis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06218914Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Washington University School of Medicine, St Louis
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 24. 9. 2026 · NCT05640999A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Washington University, St Louis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07114601A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Washington Univ. School of Medicine, St Louis
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07109726A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, St Louis
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT05123482Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Washington University School of Medicine, St Louis
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 9. 9. 2026 · NCT07166094DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Springfield
- Research Site, St Louis
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 3. 9. 2026 · NCT06989112A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- Washington University School of Medicine - Siteman Cancer Center, St Louis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07383506Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Washington University School of Medicine, St Louis
Prebieha náborFáza 1/2
12 Months – 30 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT04851119A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Washington University, Siteman Cancer Center, St Louis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT06774963A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- HCA Midwest, Kansas City
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 21. 8. 2026 · NCT05548296A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, St Louis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07182149FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Washington University School of Medicine, St Louis
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05919264A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Washington University, St Louis
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 7. 2026 · NCT04657068Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #110, St Louis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 7. 2026 · NCT06974110Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 334, Kansas City
- 521, St Louis
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 16. 7. 2026 · NCT06906341First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Saint Luke's Cancer Institute, Kansas City
- Washington University, St Louis
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT05768139Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Institute, East, Kansas City
- Saint Luke's Cancer Institute, Kansas City
- Saint Luke's Cancer Institute, Kansas City North, Kansas City
- a 3 ďalších
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - SPG, Springfield
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT07327489A Study of LY4175408 in Participants With Advanced Cancer
- Washington University, St Louis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 6. 2026 · NCT07046923Uterine Preservation Via Lifestyle Transformation
- Washington University School of Medicine, St Louis
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 20. 1. 2026 · NCT05903131Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Washington University Medical Campus, St Louis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 12. 2025 · NCT05856981Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
- Washington University School of Medicine, St Louis
Prebieha náborFáza 1
Vek 18 a viac · Ženy · Aktualizované 11. 12. 2025 · NCT06795009SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Kansas City
- Massive Bio SYNERGY-AI site, St Louis
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Mindfulness in Endometrial and Cervical Cancer
- Saint Louis University, St Louis
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 18 až 90 · Ženy · Aktualizované 30. 9. 2025 · NCT04512144Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Washington University School of Medicine, St Louis
Prebieha náborFáza 2/3
Vek 18 a viac · Ženy · Aktualizované 2. 5. 2024 · NCT05797831Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.